MFH of Bone and Osteosarcoma Show Similar Survival and Chemosensitivity
Authors:
- Dae-Geun JeonDJDae-Geun Jeon
- Won Seok SongWSWon Seok Song
- Chang-Bae KongCKChang-Bae Kong
- Jung Ryul KimJKJung Ryul Kim
- Soo-Yong LeeSLSoo-Yong Lee
- 1 February 2011
- journal article
- research article
- Published by Wolters Kluwer Health in Clinical Orthopaedics and Related Research
- Vol. 469 (2) , 584-590
Abstract
A difference in the initial tumor volume, histologic response, and survival between cohorts with MFH-B and osteosarcoma, and (2) whether histologic responses and survival rates differed between two groups even after matching for volume and age. Patients and Methods We retrospectively compared 27 patients with Stage IIB MFH-B with 389 patients with localized osteosarcoma for initial tumor volume, age, histologic response, and survival. We compared histologic response and survival between 27 patients with MFH-B and 54 patients with osteosarcoma matched for tumor volume and age. Results MFH-B occurred more frequently in older patients and they presented with a smaller mean tumor volume and more frequent osteolytic pattern when compared with patients with osteosarcoma. The 5-year metastasis-free survival rates of the MFH-B and osteosarcoma groups were similar: 61.2% ± 9.7% and 61.3% ± 2.5%, respectively. We observed similar proportions of good responders to chemotherapy in the two groups, and the 5-year metastasis-free survival rates were 61.2% ± 9.7% and 70.4% ± 6.2%, respectively. Conclusions Patients with MFH-B and osteosarcoma have similar survival rates and histologic responses to chemotherapy. Although MFH-B and osteosarcoma differ in clinical presentation, their response pattern to contemporary therapy is similar. Level of Evidence Level III, prognostic study. See the Guidelines for Authors for a complete description of levels of evidence....Keywords
This publication has 26 references indexed in Scilit:
- Prognostic effect of inadvertent curettage without treatment delay in osteosarcomaJournal of Surgical Oncology, 2009
- Prognostic effects of doctor-associated diagnostic delays in osteosarcomaArchives of orthopaedic and trauma surgery, 2009
- Malignant fibrous histiocytoma of bone: A retrospective EMSOS study of 125 casesActa Orthopaedica, 1999
- Neoadjuvant Chemotherapy for Osseous Malignant Fibrous Histiocytoma of the Extremity: Results in 18 Cases and Comparison with 112 Contemporary Osteosarcoma Patients Treated with the Same Chemotherapy RegimenJournal of Chemotherapy, 1997
- From the archives of the AFIP. Musculoskeletal malignant fibrous histiocytoma: radiologic-pathologic correlation.RadioGraphics, 1994
- The pathology of malignant fibrous histiocytoma of boneAmerican Journal of Surgical Pathology, 1985
- Malignant fibrous histiocytoma of bone the experience at the Rizzoli Institute: Report of 90 casesCancer, 1984
- Primary osteogenic sarcoma: Eight-year experience with adjuvant chemotherapyJournal of Cancer Research and Clinical Oncology, 1983
- Purely lytic osteoasarcomaSkeletal Radiology, 1982
- Primary malignant fibrous histiocytoma of boneCancer, 1975